» Articles » PMID: 9657856

Genomic Structure and Chromosome Location of the Murine PDE1B Phosphodiesterase Gene

Overview
Journal Mamm Genome
Specialty Genetics
Date 1998 Jul 10
PMID 9657856
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP, thereby participating in regulation of the intracellular concentrations of these second messengers. The PDE1 family is defined by regulation of activity by calcium and calmodulin. We have cloned and characterized the mouse PDE1B gene, which encodes the 63-kDa calcium/calmodulin-dependent PDE (CaM-PDE), an isozyme that is expressed in the CNS in the olfactory tract, dentate gyrus, and striatum and may participate in learning, memory, and regulation of phosphorylation of DARPP-32 in dopaminergic neurons. We screened an I-129/SvJ mouse genomic library and identified exons 2-13 of the PDE1B gene that span 8.4 kb of genomic DNA. Exons range from 67 to 205 nucleotides and introns from 91 to 2250 nucleotides in length. Exon 1 was not present in the 3 kb of genomic DNA 5' to exon 2 in our clones. The mouse PDE1B gene shares many similar or identical exon boundaries as well as considerable sequence identity with the rat PDE4B and PDE4D genes and the Drosophila dunce cAMP-specific PDE gene dnc, suggesting that these genes all arose from a common ancestor. Using fluorescence in situ hybridization, we localized the PDE1B gene to the distal tip of mouse Chromosome (Chr) 15.

Citing Articles

Vinpocetine, a phosphodiesterase 1 inhibitor, mitigates atopic dermatitis-like skin inflammation.

Lee Y, Song J, Lee S, Lee Y, Hwang K, Lee J Korean J Physiol Pharmacol. 2024; 28(4):303-312.

PMID: 38926838 PMC: 11211756. DOI: 10.4196/kjpp.2024.28.4.303.


PDE1B, a potential biomarker associated with tumor microenvironment and clinical prognostic significance in osteosarcoma.

Chen Q, Xing C, Zhang Q, Du Z, Kong J, Qian Z Sci Rep. 2024; 14(1):13790.

PMID: 38877061 PMC: 11178771. DOI: 10.1038/s41598-024-64627-y.


Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide.

Harms J, Menniti F, Schmidt C Front Neurosci. 2019; 13:837.

PMID: 31507355 PMC: 6716477. DOI: 10.3389/fnins.2019.00837.


Methylxanthines: Potential Therapeutic Agents for Glioblastoma.

Perez-Perez D, Reyes-Vidal I, Chavez-Cortez E, Sotelo J, Magana-Maldonado R Pharmaceuticals (Basel). 2019; 12(3).

PMID: 31500285 PMC: 6789489. DOI: 10.3390/ph12030130.


Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors.

Wu X, Huang Y, Li J, Yu Y, Qian Z, Zhang C Acta Pharm Sin B. 2018; 8(4):615-628.

PMID: 30109185 PMC: 6089849. DOI: 10.1016/j.apsb.2017.12.007.